Trial Profile
A Phase II Study Of PS-341 [bortezomib] In Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Sep 2005 New trial record.